International Stem Cell Corp. (ISCO) Subsidiary Enters Chinese Market with Cell-Based Cosmetic Products
International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, today announced its cosmoseutical subsidiary Lifeline Skin Care (www.lifelineskincare.com) has signed an agreement to distribute its anti-aging skin care products in China using the extended clinical network of one of the largest pharmaceutical companies in China, Sinopharm Group. Lifeline engages in the development, manufacturing, and commercialization of advanced skin care products based on growth factors and peptides derived from human parthenogenetic stem cells. The products, developed by ISCO's scientific team…